Glenmark Pharmaceuticals reports Q4 FY2023-24 revenue of Rs 30.63bn
Glenmark Pharmaceuticals Limited, a research-led, global pharmaceutical company, today released its financial results for the fourth quarter ending March 31, 2024, showcasing a solid performance ... Read More
Sanjivani Paranteral reports 58% growth in Q4 FY24 revenue at Rs 128.64 million
Sanjivani Paranteral Ltd (BSE: 531569), a renowned pharmaceutical company based in Mumbai with manufacturing facilities in Navi Mumbai and Dehradun, has announced impressive financial results ... Read More
Gland Pharma gains FDA approval for Edaravone Injection, set to treat ALS
Gland Pharma Limited, a prominent player in the generic injectable-focused pharmaceutical industry, has received approval from the United States Food and Drug Administration (USFDA) for ... Read More
AstraZeneca posts strong Q1 2024 results with significant revenue and EPS growth
AstraZeneca PLC has reported a notable performance in the first quarter of 2024, with total revenue reaching $12,679 million, marking a 19% increase at constant ... Read More
Lilly announces significant results in SURMOUNT-OSA trials of tirzepatide in OSA
Eli Lilly and Company (NYSE: LLY) has released positive topline results from the phase 3 SURMOUNT-OSA clinical trials, demonstrating that tirzepatide injection significantly reduces the ... Read More
Lonza to acquire Genentech’s biologics manufacturing facility in Vacaville for $1.2bn
In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global player in manufacturing for the pharmaceutical, biotech, ... Read More
Zydus Lifesciences gains FDA approval for Finasteride and Tadalafil Capsules
In a significant development for the pharmaceutical industry, Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited, has secured final approval from the United States ... Read More
Eris Lifesciences acquires Biocon Biologics’ branded formulation business for Rs 1,242cr
In a strategic move that reshapes the landscape of India's injectables market, Eris Lifesciences Ltd., a leading player in the branded formulations sector, has announced ... Read More
Strides Pharma Science secures FDA approval for Gabapentin tablets
In a notable advancement for neuropathic pain treatment, Strides Pharma Science Limited (Strides) has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. ... Read More
Venus Remedies receives significant boost with PLI Scheme disbursement
Venus Remedies Ltd, a leading player in India's generic drug manufacturing sector, has recently been awarded a pivotal disbursement of Rs 7.5 crore under the ... Read More